Published

Set and setting predict psychopathology, wellbeing and meaningfulness of psychedelic experiences: a correlational study.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Expert review of clinical pharmacology
Date: 2024-01-01
Source: PubMed
DOI: 10.1080/17512433.2023.2295997
PubMed: 38108102

Authors

Borkel LF Rojas-Hernández J Henríquez-Hernández LA Santana Del Pino Á Quintana-Hernández DJ

Watch author

Derived topics and classifications

psilocybin Addiction Wellbeing Personality Change Clinical Trial Observational Study Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 2 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin-containing mushroom-assisted psychotherapy is associated with sustained psychological and somatic improvements: two case studies from Jamaica2026-07-29 Set and setting predict psychopathology, wellbeing and meaningfulness of psychedelic experiences: a correlational study.2024-01-01

Related papers

Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experiencePsychedelics · 2025-11-20 Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondentsPsychedelics · 2025-11-15 Retreat from racism: A psychedelic group experience for racial stress and traumaPsychedelics · 2026-07-30 Integration in classic psychedelic-assisted therapies for mental health conditions: A scoping reviewPsychedelics · 2026-07-26 Psychedelics in the context of stress and psychiatric disorders: A new horizon in mental health treatmentPsychedelics. · 2025-10-14 PRoMiSS: Psilocybin and the Role of Music in Set and SettingClinicalTrials.gov · 2025-09-18 Gregor Hasler: Three Guiding Questions - How do psychedelics shape the brain? How can they heal psychiatric disorders such as depression and PTSD? How can we ensure their safe and responsible use?Psychedelics. · 2025-09-02 Stephen Ross: Psychedelic-assisted therapies for difficult-to-treat psychiatric and medical disordersPsychedelics. · 2025-06-10